Halyard Health, Inc. (NYSE:HYH) reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $45.72 and last traded at $45.71, with a volume of 132,709 shares trading hands. The stock had previously closed at $45.37.

A number of research firms recently issued reports on HYH. Stephens raised shares of Halyard Health from an “equal weight” rating to an “overweight” rating in a research note on Thursday, August 3rd. BidaskClub raised shares of Halyard Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 19th. Deutsche Bank AG upped their price target on shares of Halyard Health from $35.00 to $42.00 and gave the company a “buy” rating in a research note on Thursday, August 3rd. Zacks Investment Research raised shares of Halyard Health from a “hold” rating to a “buy” rating and set a $44.00 price target on the stock in a research note on Wednesday, July 12th. Finally, TheStreet raised shares of Halyard Health from a “c” rating to a “b” rating in a research note on Thursday, June 22nd. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Halyard Health currently has an average rating of “Buy” and a consensus price target of $42.25.

The stock’s 50 day moving average price is $42.26 and its 200-day moving average price is $39.35. The firm has a market cap of $2.13 billion, a P/E ratio of 43.94 and a beta of 1.76.

Halyard Health (NYSE:HYH) last issued its quarterly earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.14. Halyard Health had a return on equity of 8.29% and a net margin of 3.06%. The business had revenue of $399.20 million for the quarter, compared to the consensus estimate of $399.16 million. During the same quarter in the previous year, the company posted $0.45 earnings per share. Halyard Health’s revenue for the quarter was down .2% compared to the same quarter last year. On average, analysts forecast that Halyard Health, Inc. will post $1.98 EPS for the current year.

Several hedge funds have recently modified their holdings of the company. BlackRock Inc. grew its holdings in shares of Halyard Health by 6,362.1% during the first quarter. BlackRock Inc. now owns 5,939,352 shares of the medical instruments supplier’s stock valued at $226,229,000 after buying an additional 5,847,442 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Halyard Health by 4.7% during the first quarter. Vanguard Group Inc. now owns 4,350,518 shares of the medical instruments supplier’s stock valued at $165,711,000 after buying an additional 196,367 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Halyard Health by 19.3% during the second quarter. Dimensional Fund Advisors LP now owns 3,133,049 shares of the medical instruments supplier’s stock valued at $123,067,000 after buying an additional 507,893 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of Halyard Health by 242.8% during the second quarter. Goldman Sachs Group Inc. now owns 1,864,646 shares of the medical instruments supplier’s stock valued at $73,244,000 after buying an additional 1,320,735 shares in the last quarter. Finally, State Street Corp grew its holdings in shares of Halyard Health by 7.5% during the second quarter. State Street Corp now owns 1,702,423 shares of the medical instruments supplier’s stock valued at $66,872,000 after buying an additional 119,154 shares in the last quarter. Institutional investors and hedge funds own 91.02% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://www.dailypolitical.com/2017/09/07/halyard-health-inc-hyh-reaches-new-52-week-high-at-45-72.html.

About Halyard Health

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.